Industry & Business

Aerogen, the global leader in aerosol drug delivery, has been named as a Ruban d’Honneur recipient for excellence in innovation and financial success in the prestigious 2015/2016 RSM European Business Awards.  Aerogen will now represent Ireland in the final to become overall Entrepreneur of the Year.

The prestigious accolade comes as Aerogen, which employs over 100 people in Ireland, reported 30% business growth year on year for the past eight years, surpassing annual growth targets.  Having invested over €40 million in creating a breakthrough high performance nebuliser and setting a new standard of aerosol drug delivery in critical care, Aerogen products are supplied to over 75 countries and to date have benefitted over three million patients worldwide.

On the back of two new product launches in 2015 the company’s Aerogen Solo alongside the recently released Aerogen Ultra product, as of 2016 are being used for aerosol drug delivery in both the Operating Room and the Emergency Department. This now gives Aerogen acute care users the ability to offer the same clinical benefits to patients in these departments as well as ICU. This is part of the company’s diffusion strategy which today sees a new patient introduced to Aerogen technology every 30 seconds.

Commenting on the award, John Power, Aerogen CEO, said: “We are honoured, to be named a Ruban d’Honneur recipient by the European Business Awards and look forward to representing Ireland in the final round. This is a great achievement for the company and we are delighted to be held in such high regard alongside other leading businesses across Europe.   At Aerogen we strive for excellence and are proud to be an Irish business that is the global leader in the area of respiratory care.”

As Europe’s largest and most significant cross-sector business recognition programme, the European Business Awards comprise three rigorous judging phases.   Aerogen is one of only two Irish companies chosen from 678 other National Champions from across Europe to receive the Ruban d’Honneur, which was conferred in recognition of its enterprise expansion, innovation and success.

Now in its 9th Year, the European Business Awards were created to celebrate and promote business success and support the development of a stronger and more successful business community throughout Europe.

Aerogen is an international medical device and drug delivery company. Founded in 1997, Aerogen was first to market with a palladium vibrating mesh nebuliser for the acute care setting and has become the standard of care. Today its products are sold in over 75 countries, and it has partnered its technology with world leading companies including Philips Healthcare, GE Healthcare, Covidien, Maquet, Drager, Hamilton and ResMed.